As of 2025-10-30, the EV/EBITDA ratio of Sutro Biopharma Inc (STRO) is -0.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STRO's latest enterprise value is 24.98 mil USD. STRO's TTM EBITDA according to its financial statements is -193.69 mil USD. Dividing these 2 quantities gives us the above STRO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.1x - 15.2x | 15.1x |
| Forward P/E multiples | 15.0x - 22.2x | 20.1x |
| Fair Price | (33.47) - (33.93) | (39.46) |
| Upside | -3287.9% - -3331.4% | -3858.1% |
| Date | EV/EBITDA |
| 2025-10-29 | -0.13 |
| 2025-10-28 | -0.15 |
| 2025-10-27 | -0.18 |
| 2025-10-24 | -0.13 |
| 2025-10-23 | -0.13 |
| 2025-10-22 | -0.18 |
| 2025-10-21 | -0.19 |
| 2025-10-20 | -0.17 |
| 2025-10-17 | -0.11 |
| 2025-10-16 | -0.05 |
| 2025-10-15 | -0.01 |
| 2025-10-14 | -0.02 |
| 2025-10-13 | -0.03 |
| 2025-10-10 | -0.02 |
| 2025-10-09 | -0.04 |
| 2025-10-08 | -0.04 |
| 2025-10-07 | -0.04 |
| 2025-10-06 | -0.05 |
| 2025-10-03 | -0.07 |
| 2025-10-02 | -0.06 |
| 2025-10-01 | -0.06 |
| 2025-09-30 | -0.05 |
| 2025-09-29 | -0.05 |
| 2025-09-26 | -0.06 |
| 2025-09-25 | -0.05 |
| 2025-09-24 | -0.05 |
| 2025-09-23 | -0.03 |
| 2025-09-22 | -0.06 |
| 2025-09-19 | -0.06 |
| 2025-09-18 | -0.06 |
| 2025-09-17 | -0.04 |
| 2025-09-16 | -0.06 |
| 2025-09-15 | -0.06 |
| 2025-09-12 | -0.05 |
| 2025-09-11 | -0.09 |
| 2025-09-10 | -0.07 |
| 2025-09-09 | -0.09 |
| 2025-09-08 | -0.10 |
| 2025-09-05 | -0.13 |
| 2025-09-04 | -0.12 |
| 2025-09-03 | -0.11 |
| 2025-09-02 | -0.09 |
| 2025-08-29 | -0.04 |
| 2025-08-28 | -0.06 |
| 2025-08-27 | -0.06 |
| 2025-08-26 | -0.06 |
| 2025-08-25 | -0.04 |
| 2025-08-22 | -0.04 |
| 2025-08-21 | -0.04 |
| 2025-08-20 | -0.05 |